Fmr LLC boosted its stake in shares of ICU Medical, Incorporated (NASDAQ:ICUI) by 87.4% in the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 218,602 shares of the medical instruments supplier’s stock after purchasing an additional 101,972 shares during the period. Fmr LLC’s holdings in ICU Medical were worth $61,810,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Cerebellum GP LLC bought a new position in ICU Medical during the third quarter valued at about $186,000. Mackay Shields LLC bought a new position in ICU Medical during the second quarter valued at about $205,000. CIBC Asset Management Inc bought a new position in ICU Medical during the second quarter valued at about $209,000. MML Investors Services LLC bought a new position in ICU Medical during the third quarter valued at about $217,000. Finally, First Hawaiian Bank bought a new position in ICU Medical during the third quarter valued at about $226,000. Institutional investors own 75.87% of the company’s stock.

Shares of NASDAQ:ICUI opened at $218.72 on Tuesday. The stock has a market cap of $4.54 billion, a price-to-earnings ratio of 39.62 and a beta of 0.63. ICU Medical, Incorporated has a twelve month low of $211.25 and a twelve month high of $321.70.

ICU Medical (NASDAQ:ICUI) last issued its earnings results on Thursday, November 8th. The medical instruments supplier reported $1.85 earnings per share for the quarter, topping analysts’ consensus estimates of $1.51 by $0.34. The firm had revenue of $327.20 million during the quarter, compared to analyst estimates of $334.97 million. ICU Medical had a net margin of 6.00% and a return on equity of 15.20%. The company’s quarterly revenue was down 4.7% on a year-over-year basis. During the same quarter last year, the business earned $1.12 earnings per share. On average, sell-side analysts expect that ICU Medical, Incorporated will post 7.76 EPS for the current fiscal year.

A number of brokerages have weighed in on ICUI. TheStreet upgraded shares of ICU Medical from a “c+” rating to a “b+” rating in a research report on Monday, August 20th. ValuEngine upgraded shares of ICU Medical from a “hold” rating to a “buy” rating in a research report on Tuesday, October 2nd. BidaskClub upgraded shares of ICU Medical from a “hold” rating to a “buy” rating in a research report on Friday, September 28th. Finally, Zacks Investment Research lowered shares of ICU Medical from a “strong-buy” rating to a “hold” rating in a research report on Thursday, October 11th.

In other ICU Medical news, Director Pfizer Inc sold 2,500,000 shares of the stock in a transaction dated Thursday, November 15th. The shares were sold at an average price of $209.25, for a total transaction of $523,125,000.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 12.50% of the stock is owned by company insiders.

ILLEGAL ACTIVITY WARNING: “Fmr LLC Boosts Position in ICU Medical, Incorporated (ICUI)” was reported by Daily Political and is the property of of Daily Political. If you are reading this news story on another website, it was copied illegally and republished in violation of U.S. and international copyright law. The original version of this news story can be accessed at https://www.dailypolitical.com/2018/12/18/fmr-llc-boosts-position-in-icu-medical-incorporated-icui.html.

ICU Medical Profile

ICU Medical, Inc develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein.

Recommended Story: What is Cost of Capital?

Want to see what other hedge funds are holding ICUI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ICU Medical, Incorporated (NASDAQ:ICUI).

Institutional Ownership by Quarter for ICU Medical (NASDAQ:ICUI)

Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.